Efficacy of Topical Azithromycin versus Systemic Doxycycline in Treatment of Meibomian Gland Dysfunction

Table 1

Demographic data of the studied groups.

Age (years)		Topical azithromycin (n = 28)	Systemic doxycycline (n = 28)	value
		30.11 ± 12.12	35.00 ± 14.14	0.170
		15–56	16–60
Gender	Male	16 (57.14%)	18 (64.29%)	0.584
	Female	12 (42.86%)	10 (35.71%)

Data are presented as mean ± SD.